The domestic pharmaceutical market is set to witness an interesting development tomorrow, as one of the most widely prescribed diabetes drugs, Vildagliptin, would see its price fall by as much…Read More
Investors are pricing in high growth from the domestic arm of global pharmaceutical behemoth Pfizer Inc. The Pfizer Ltd stock gained nearly 36% in the last two months against the Nifty Pharma Index’s…Read More
The UK government has allowed Amazon to access health data under the National Health Service (NHS) for free which the tech giant will use for Alexa-driven medical advice for patients….Read More
A new study can spot and remove pathogens such as Candida albicans, a commonly found microbe that can turn deadly when it colonises on medical devices such as catheters implanted…Read More
France’s Sanofi (SASY.PA) on Monday agreed to buy California-headquartered biotechnology firm Synthorx (THOR.O) in a cash deal worth about $2.5 billion as it steps up a push in the lucrative…Read More
Bristol-Myers Squibb Co on Saturday said that an experimental cancer therapy it acquired as part of its $74 billion deal for Celgene Corp produced positive results in a clinical trial….Read More
Metro Pacific Investments Corporation (“MPIC”) (PSE: MPI), global investment firm KKR, and GIC, Singapore’s sovereign wealth fund, today announced the completion of investments in Metro Pacific Hospital Holdings, Inc. (“Metro…Read More
Algiax Pharmaceuticals, a clinical-stage biotechnology company focused on development of GABAA receptor modulators for neuropathic pain and other indications with unmet medical need, announced to have secured financing for its development…Read More
Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has signed a strategic partnership agreement with OG DNA Genetics Inc….Read More
Healx Ltd. (“Healx”), the AI-powered biotechnology company focused on developing breakthrough treatments for rare diseases, today announces it has entered into an agreement with Boehringer Ingelheim to identify indications related…Read More
Silverleaf Venture Partners LLC (“Silverleaf”) a cannabis industry investment manager has launched a strategic partnership with Hedgeye, a research firm which covers individual public companies involved in the cannabis industry…Read More
Biologics and bioprinting company 3DBio Therapeutics has secured rare paediatric disease status from the US Food and Drug Administration (FDA) for its AuriNovo living ear-shaped tissue. AuriNova is an investigational…Read More
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced initial clinical data for REGN5458, a BCMAxCD3 bispecific antibody, in patients with relapsed or refractory (R/R) multiple myeloma. BCMA (B-cell maturation antigen) is a protein…Read More
Johnson & Johnson (NYSE: JNJ) today announced that its Janssen Pharmaceutical Companies will provide up to 200,000 Ebola vaccine regimens to the Republic of Rwanda. This commitment will support a new immunization program led…Read More
GE Healthcare Life Sciences and Advanced Solutions Life Sciences (ASLS) will enter into a strategic R&D and distribution partnership that sets out to personalize tissue regeneration. The integration of IN Cell Analyzer and…Read More
